Skip to content
  • Sunday, 26 July 2026
  • 1:41 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Researchers Identify Cellular Energy Deficits as Key Biological Marker for Early Stage Major Depression
Neuroscience & Brain Research

Researchers Identify Cellular Energy Deficits as Key Biological Marker for Early Stage Major Depression

Rifan Muazin Mar 14, 2026 0

In a collaborative breakthrough that may redefine the clinical understanding of psychiatric disorders, researchers from the University of Queensland and…

Read More
Neuroscience & Brain Research

Microplastics and Neurodegeneration: New Research Links Synthetic Particles to Alzheimer’s and Parkinson’s Disease Risks

Rifan Muazin Mar 14, 2026 0

The global escalation of plastic pollution has long been recognized as a primary threat to marine ecosystems and environmental stability,…

Read More

Posts pagination

1 … 39 40
Scientific Breakthrough Confirms Pianists Shape Timbre Through Touch Precision and Motor ControlBreakthrough in Quantum Key Distribution Achieved via On-Demand Telecom Quantum Dots and Time-Bin Encoding Over 120 Kilometers of FiberNature’s Proton Highway Revealed: Scientists Unravel Molecular Secrets of Charge Transport in Biological Systems and BeyondLoss of TDP-43 in microglia linked to neurological disease development
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ